SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India · Delayed Price · Currency is INR 381.50
-44.35 (-10.41%)
May 22, 2026, 3:30 PM IST
SMS Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,020 | 691.36 | 498.26 | -70.59 | 622.2 |
Depreciation & Amortization | 399.19 | 342.16 | 314.67 | 320.72 | 320.93 |
Other Amortization | 2.21 | 2.68 | 2.05 | 2.2 | 2.51 |
Loss (Gain) From Sale of Assets | - | -0.21 | -0.37 | 0.54 | -0.02 |
Loss (Gain) From Sale of Investments | -5.46 | 9.75 | 2.25 | 2.01 | 1.56 |
Other Operating Activities | 116.27 | 202.13 | 229.88 | 282.52 | 87.18 |
Change in Accounts Receivable | -126.33 | 330 | -878.47 | -998.27 | 571.61 |
Change in Inventory | -664.77 | -510.31 | -101.98 | 275.98 | -1,133 |
Change in Accounts Payable | 65.17 | -374.06 | 438.68 | 424.37 | 74.18 |
Change in Income Taxes | -8.31 | 15.34 | 43.06 | 32.91 | -14.58 |
Change in Other Net Operating Assets | -205.62 | 108.26 | -46.77 | -47.89 | -81.85 |
Operating Cash Flow | 592.24 | 817.09 | 501.25 | 224.5 | 450.6 |
Operating Cash Flow Growth | -27.52% | 63.01% | 123.27% | -50.18% | -50.19% |
Capital Expenditures | -1,306 | -1,234 | -521.6 | -299.21 | -272.47 |
Sale of Property, Plant & Equipment | - | 0.56 | 0.88 | 2.63 | 0.17 |
Investment in Securities | - | -0.15 | -0.07 | -1.68 | - |
Other Investing Activities | -2.22 | -0.9 | 0.07 | 0.69 | 0.77 |
Investing Cash Flow | -1,308 | -1,234 | -520.72 | -297.56 | -271.53 |
Short-Term Debt Issued | 261.05 | 108.03 | 202.07 | 258.77 | 8.89 |
Long-Term Debt Issued | 623.19 | 637.24 | 450.86 | 94.14 | 451.9 |
Total Debt Issued | 884.24 | 745.27 | 652.93 | 352.91 | 460.79 |
Short-Term Debt Repaid | - | - | - | - | -38.35 |
Long-Term Debt Repaid | -343.52 | -447.99 | -388.01 | -437.93 | -337.45 |
Total Debt Repaid | -343.52 | -447.99 | -388.01 | -437.93 | -375.8 |
Net Debt Issued (Repaid) | 540.72 | 297.28 | 264.92 | -85.02 | 84.99 |
Common Dividends Paid | -35.46 | -33.86 | -25.4 | -25.4 | -25.4 |
Other Financing Activities | 255.09 | 207.37 | 67.26 | -209.28 | -177.06 |
Financing Cash Flow | 760.35 | 470.79 | 306.79 | -319.69 | -117.47 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - |
Net Cash Flow | 44.78 | 53.6 | 287.32 | -392.75 | 61.6 |
Free Cash Flow | -713.35 | -416.71 | -20.35 | -74.71 | 178.12 |
Free Cash Flow Margin | -7.97% | -5.32% | -0.29% | -1.43% | 3.43% |
Free Cash Flow Per Share | -7.80 | -4.70 | -0.24 | -0.88 | 2.10 |
Cash Interest Paid | - | 173.53 | 217.52 | 209.28 | 177.06 |
Cash Income Tax Paid | - | 198.33 | 154 | 46 | 149.2 |
Levered Free Cash Flow | -898.87 | -694.83 | -252.73 | -316 | -224.79 |
Unlevered Free Cash Flow | -756.86 | -587.33 | -112.92 | -186.46 | -113.22 |
Change in Working Capital | -939.86 | -430.78 | -545.48 | -312.89 | -583.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.